We would like to share ideas on the publication, “Closer to the Patient Means Better Decisions: Wearable Remote Monitoring of Patients with COVID-19 Lung Disease.”1 Izmailova and Reiss concluded that “Remote patient monitoring might give an answer to the numerous questions about … interventions to mitigate the morbidity and mortality effects of this ongoing virus pandemic.”1 Izmailova and Reiss discussed on usefulness of several remote monitoring devices. For a diagnostic investigation that the remote monitoring tool might not be applied, such as an imaging study, the mobile point of care investigation might be used instead. The remote monitoring devices can help increase safety in clinical management of coronavirus disease 2019 (COVID-19). Nevertheless, there are many considerations to be addressed. First, the patient who wears a remote monitoring tool has to be well-educated. In additional, a good telecommunication system must be available.2 In our setting, most patients are low educated and the network is poor. Hence, remote patient monitoring is usually difficult. When the number of new COVID cases increases, facilities are limited for monitoring at the same time. Moreover, the cost of the remote monitoring equipment is high and it is usually unaffordable. Finally, although there might be a favorable outcome of remote patient monitoring, a continuous improvement process by applying lessons learned is necessary.2 According to a previous study, mortality was less than 0.5%.3 To achieve high-quality health care, no mortality should be the target.

The authors declared no competing interests for this work.